Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial Dehydroepiandrosterone
Lust, John Anthony
Mayo Clinic, Rochester, Rochester, MN, United States
Search 4 grants from John Lust
Search grants from Mayo Clinic, Rochester
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Start Healthy, Start Now
Creating a foundation for the design of culturally-informed health IT
Tuberculosis Research Unit
Small Instrumentation Program
SBIR Phase I: Dual suppression of VEGF-A and PDGF-B with extended gene therapy for neovascular AMD
Recently added grants:
Regulation of T cell responses to oral antigens
Dissecting the pathways controlling tunable responses to TCR signaling
Wimpy antibody isotypes protect against antibody-mediated disease
Epigenome-wide association study of childhood asthma
Fungal and Host Factors in Initiation of Cryptococcal Persistence
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN065125-000
Application #
2371351
Study Section
Project Start
1996-09-27
Project End
Budget Start
1996-09-27
Budget End
2001-09-29
Support Year
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Related projects
NIH 2005
N01 CN
Phase 2 Clinical Trial-Dehydroepiandrosterone in Monoclonal Gammopathy-261065125
/ Mayo Clinic, Rochester
NIH 1996
N01 CN
Phase II Clinical Trial Dehydroepiandrosterone
Lust, John Anthony / Mayo Clinic, Rochester
Comments
Be the first to comment on this grant